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Introduction
This paper [1] published in November 2002 in the journal
Physics in Medicine & Biology describes two new predic-
tion models which were devised by R.F. Mould by extend-
ing and modifying the concept of the original lognormal
model [2,3], which was reviewed in Nowotwory in 2001
[4]. The epidemiological concept underlying the Tobacco
Cancer Risk model was the correlation of tobacco smok-
ing with cancers of the larynx and lung. Thus a laryngeal
cancer patient who after being cured of this neoplasm, can
several years later also suffer from a second primary lung
cancer. The validation test data used for this study is
unique in that all ~ 1000 patients with localised [T1N0,
T2N0 or T3N0] cancer of the larynx were treated [1944-
68] by the same radiotherapist: Dr Manuel Lederman of
the Royal Marsden Hospital, London. Follow-up was
available to 1988.
In addition, data for ~ 6000 patients from Con-
necticut and from Metropolitan Detroit Cancer Registries
with cancers of the breast, prostate, cervix uteri, thyroid,
tongue and bladder treated 1973-1977 with follow-up to
1999 were obtained from the US Surveillance, Epide-
miology and End Results [SEER] Program of the National
Cancer Institute. Results showed that the methodology
for the SLN, TCR and ACC models could be extended
from cancer of the larynx to other cancers: thus making
these models more powerful for cancer research.
The work in this paper showing that cancer can be
totally cured sends a positive message on cancer to
patients, physicians and surgeons for a disease which all
too often, even if mistakenly where early stage tumours
are concerned, seems to imply in the public view, all doom
and gloom.
The Abstract from Physics in Medicine & Biology is
reproduced below together with Figures 1, 2 and 5 and
Table 12 from this PMB paper.
Abstract
Three parametric statistical models have been fully
validated for cancer of the larynx for the prediction of
long-term 15, 20 and 25 year cancer-specific survival
Varia statistica
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To date it has been generally assumed for early stage disease that
although for some 5-10 years after treatment the survival experience
of this patient subgroup might be no different from that expected in
the matched group, thereafter the death rate of this subgroup
becomes lower than that of the matched group. This implies that
surviving cancer patients cured of their disease tend to die of other
conditions at a higher than normal rate as they become older, and
therefore cancer is never totally cured. Our conclusion is that at
least for cancer of the glottic larynx, the answer to the question
"Can cancer totally be cured?" is "Yes to at least 15-years post-
treatment and also probably to 25 years". 
Table 12
Complete life analysis to 15-years post-treatment for 294 stage T1N0 and 145 stage T2N0 cases where all patients are excluded who have died with cancer
of the larynx present or with cancer of the lung present. For stage T1N0 and T2N0 and survival time T=10-20 years agreement, is less than or equal to
1 standard error of the observed T-year survival fraction calculated using the Kaplan-Meier method [5]. These results show that the Haybittle [7] definition
of cancer cure as understood by the man-in-the-street has been achieved: "The complete elimination of disease, so that a patient cured of cancer would
be one whose subsequent medical history and length of life was completely unaffected by their having had cancer".
Survival Ca. Larynx Stage T1N0 Ca. Larynx Stage T2N0
time Survival fractions Standard Survival fractions Standard
T years Observed Expected error Observed Expected error
SF SF of Observed SF SF SF of Observed SF
5 0.86 0.81 0.02 0.87 0.82 0.03
10 0.65 0.63 0.03 0.62 0.64 0.04
15 0.46 0.45 0.03 0.46 0.48 0.04
20 0.34 0.31 0.03 0.30 0.34 0.04
25 0.23 0.19 0.03 0.27 0.23 0.04
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fractions when short-term follow-up data was available
for just 1-2 years after the end of treatment of the last
patient. In all groups of cases the treatment period was
only 5 years. Three disease stage groups were studied,
T1N0, T2N0 and T3N0. The models are the Standard
Lognormal (SLN) first proposed by Boag in 1949 [2] but
only ever fully validated for cancer of the cervix, Mould
and Boag in 1975 [3] and two new models which have
been termed Tobacco Cancer Risk (TCR) and Absolute
Cancer Cure (ACC).
In each, the frequency distribution of survival times
of defined groups of cancer deaths is lognormally dis-
tributed: larynx only (SLN), larynx and lung (TCR) and
all cancers (ACC). All models each have three unknown
parameters but it was possible to assume a value for the
lognormal parameter S a priori. By reduction to two
unknown parameters the model stability has been
improved.
The material used to validate the methodology con-
sisted of case histories of 965 patients, all treated during
the period 1944-1968 by Dr Manuel Lederman of the
Royal Marsden Hospital, London, with follow-up to 1988.
This provided a follow-up range of 20-44 years and
enabled predicted long-term survival fractions to be com-
pared with the actual survival fractions, calculated by the
Kaplan and Meier method [5].
The TCR and ACC models are better than the SLN
model and for a maximum short-term follow-up of 6
years, the 20 and 25 year survival fractions could be pre-
dicted. Therefore the number of follow-up years saved are
Figure 1. Schematic diagram for the three prediction models studied in which the statistically cured fraction of
patients is denoted by C. For a given long-term survival time τ years the tail of the lognormal distribution, denoted
by Q, will be the longest for the ACC model and the shortest for the SLN model.
Figure 2. Schematic diagram illustrating the concept of the Phase 2 validation procedure. The Phase 1 validation
procedure consists of a minimum chi-squared test for lognormality of the observed survival times for a given
model: SLN, TCR or ACC.
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respectively 14 years and 19 years. Clinical trial results
using the TCR and ACC models can thus be analysed
much earlier than currently possible.
Absolute cure from cancer was also studied, using
not only the prediction models which incorporate a para-
meter for a statistically cured fraction of patients CSLN,
CTCR and CACC, but because of the long follow-up range
of 20-44 years, also by Complete Life Analysis. The survival
experience of those who did not die of their original can-
cer of the larynx was compared to the expected survival
experience of a population with the same age, birth cohort
and sex structure.
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Figure 5. Comparison of observed and expected survival rates on a semi-
logarithmic graph plot for stage T1N0 cancer of the larynx patients. This
demonstrates the concept of statistical cure proposed by Easson and
Russell of the Christie Hospital, Manchester [6] in 1968. This was
described in the following terms "If a group of patients subsequently
show an annual death rate from all causes which is similar to that of the
normal population of the same age and sex structure, then this group can
be said to be cured".
